Clinical Trial Update: Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating PROVIGIL (modafinil) for excessive daytime sleepiness in children and adolescents with obstructive sleep apnea/hypopnea syndrome has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Provigil (Modafinil)

Snippet

Sponsor: Cephalon | Conditions: Sleep Apnea, Obstructive | Phase 3 | Status: COMPLETED